MIR6090

Across TCGA pan-cancer cohorts, MIR6090 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR6090 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher MIR6090 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6090 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

PAAD, LGG, and HNSC are the cancer types where MIR6090 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.177	0.645	.001	36	view →
LGG	OS	Tertile	All	0.435	0.815	<.001	36	view →
HNSC	OS	Tertile	II,III,IV	0.465	0.746	.020	36	view →
STAD	DFS	Quartile	All	0.562	0.759	.008	25	view →
BLCA	DFS	Tertile	III,IV	0.237	0.580	.002	18	view →
KIRP	OS	Tertile	IV	0.111	0.503	<.001	18	view →
DLBC	DFS	Tertile	All	0.137	0.804	.013	18	view →
CESC	DFS	Tertile	III,IV	0.240	0.726	.015	18	view →
ESCA	DFS	Tertile	IV	0.221	0.539	.046	12	view →
THCA	DFS	Tertile	III,IV	0.203	0.752	.010	6	view →
SKCM	DFS	Tertile	All	0.785	0.610	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR6090–PAAD (OS)

Open the PAAD breakdown →